Eplontersen, a second-generation ASO, employs a GalNAc-conjugated delivery system for enhanced liver targeting, increased safety, 283 and decreased dosing frequency
In trials focused on people with type 2 diabetes, a population already at elevated heart risk, GLP-1s consistently reduced serious cardiovascular events by 1226% depending on the drug and population, with strong results for stroke prevention
The high autoantibody levels were associated with several findings suggestive of thyroid hormone failure: particularly low enzyme activity, low free T3 levels, low total T3 to total T4 (TT3/TT4), and low free T3 to free T4 (FT3/FT4) ratios
It is important to note that since the drug is still being studied in clinical trials, researchers are still learning its full effects
Our in-house and third-party testing protocols ensure consistent 98-102% purity, correct isomeric composition, and compliance with all regulatory specifications before release to customers
Verify your benefits before booking Klaritys team can help you understand what your plan may cover so there are no surprises at billing time